Related Experiment Video
Updated: Sep 17, 2025
13:04
Overexpressing Long Noncoding RNAs Using Gene-activating CRISPR
Published on: March 1, 2019
9.0K
LncRNA CTD-2555A7.2 promotes bone formation with LncRNA-specific cascade amplification strategy.
Fanjin Meng1, Kaiyuan Zheng2,1, Meng Deng1
1School of Laboratory Medicine, Translational Medicine Research Center, North Sichuan Medical College, Nanchong, 637000, Sichuan, China.
Scientific Reports
|July 1, 2025
Summary
Long non-coding RNA CTD-2555A7.2 enhances bone formation by interacting with miR-381-3p. This discovery offers a novel therapeutic strategy for osteoporosis treatment.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- Osteoporosis is a major health concern.
- Long non-coding RNAs (LncRNAs) are key regulators in osteoporosis.
- Improving LncRNA-mediated bone formation is crucial.
Purpose of the Study:
- Investigate the role of LncRNA CTD-2555A7.2 in osteogenesis.
- Elucidate the mechanism of CTD-2555A7.2 in bone formation.
- Explore therapeutic potential for osteoporosis.
Main Methods:
- In vitro and in vivo functional analyses (over-expression, siRNA silencing).
- Western blot and luciferase reporter assays.
- Assessment in ovariectomy osteoporosis models.
Main Results:
- CTD-2555A7.2 enhances bone formation by sequestering miR-381-3p via its repeat sequence.
- miR-381-3p targets Apc, Lef1, wnt5a, and Lrp6, suppressing osteogenic differentiation.
- CTD-2555A7.2 repeat sequence showed therapeutic efficacy in osteoporosis models.
Conclusions:
- Identified a dual-amplification osteogenic axis (CTD-2555A7.2-miR-381-Wnt) regulating osteoporosis.
- Established a framework for understanding osteogenic LncRNA mechanisms.
- Provided insights for novel osteoporosis therapeutics.
